Abstract
A pharmaceutical composition for parenteral administration, comprising liposomes composed of non-charged vesicle-forming lipids, including up to 20 mole percent of an amphipathic vesicle-forming lipid derivatized with polyethyleneglycol, and optionally including not more than 10 mole percent of negatively charged vesicle-forming lipids, the liposomes having a selected mean particle diameter in the size range between about 40-200 nm and containing a water soluble corticosteroid for the site-specific treatment of inflammatory disorders, is provided.
| Original language | English |
|---|---|
| Patent number | US2004037875 |
| IPC | A61P 29/ 00 A I |
| Priority date | 7/12/01 |
| Publication status | Published - 26 Feb 2004 |